|
|||||
|
|
Postprandial renal haemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized,double-blind trial |
|
| Authors: | Marcel H A Muskiet MD Lennart Tonneijck MD Mark M Smits MD Mark H H Kramer MD D Margriet Ouwens PhD Bolette Hartmann PhD Jens J Holst PhD A H Jan Danser MD Jaap A Joles DVM Daniël H van Raalte MD |
| Institution: | 1. Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands;2. Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center, Dusseldorf, Germany
German Center for Diabetes Research (DZD), Muenchen-Neuherberg, Germany Department of Endocrinology, Ghent University Hospital, Ghent, Belgium;3. Department of Biomedical Sciences, Panum Institute, University of Copenhagen, Copenhagen, Denmark;4. Department of Internal Medicine, Division of Pharmacology and Vascular Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands;5. Department of Nephrology and Hypertension, University Medical Center, Utrecht, The Netherlands |
| Abstract: | |
| Keywords: | dipeptidyl peptidase-4 DPP-4 inhibitor glomerular filtration rate linagliptin postrandial hyperfiltration sulphonylurea type 2 diabetes |